CXCL10 and systemic lupus erythematosus: Furthermore, we showed that galectin‐9 and CXCL10 were relatively specific for autoinflammatory myopathies in adult and pediatric patients, as their levels were not as highly increased or did not differentiate between active disease and remission in other autoimmune diseases such as localized scleroderma and SLE.